warnings
WARNINGS Avoid contact with eyes, lips and mucous membranes.
DERMACURE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- DERMACURE
- Generic name
- UREA 41%
- Manufacturer
- Oncora Pharma, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 3f5bc584-a52f-3b5e-e063-6294a90a5674
- SPL ID
- 3f5bc584-a52c-3b5e-e063-6294a90a5674
- Version
- 1
- Effective date
- 2025-09-21
- Source export date
- 2026-11-06
- Source partition
- 9
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/5731a8c92e1c0dd2a09d2f92b410e7a70ea29cbf6b8040a6a05e4be5b7c51f0d/drug-label-0009-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 07:44:42
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | DERMACURE | openfda.brand_name | |
| generic name | UREA 41% | openfda.generic_name | |
| manufacturer name | Oncora Pharma, LLC | openfda.manufacturer_name | |
| ndc | package | 85477-909-30 | openfda.package_ndc |
| ndc | product | 85477-909 | openfda.product_ndc |
| ndc11 | package | 85477090930 | derived:openfda.package_ndc |
| rxcui | 1436933 | openfda.rxcui | |
| spl id | 3f5bc584-a52c-3b5e-e063-6294a90a5674 | id | |
| spl set id | 3f5bc584-a52f-3b5e-e063-6294a90a5674 | set_id | |
| unii | 8W8T17847W | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Discontinue use and consult a physician if redness or irritation occurs.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.